Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Hydralazine / Isosorbide Dinitrate Oral Tablet [Bidil]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
In 2005 the FDA approved BiDil, the first drug ever to include a race-specific indication on its label - to treat heart failure… Expand
Is this relevant?
2007
2007
rappelle l’édifiante histoire du BiDil, l’association d’isosorbide dinitrate et d’hydralazine (I/H) pour le traitement de l… Expand
Is this relevant?
2006
2006
  • J. Z. Garrod
  • McGill journal of medicine : MJM : an…
  • 2006
  • Corpus ID: 11986825
constructed, was always rooted in 'biological' features; that is, the characteristics used to classify individuals into races… Expand
Is this relevant?
2006
2006
When the US Food and Drug Administration licensed the drug BiDil® in June 2005 it was hailed as a significant step towards… Expand
Is this relevant?
2006
2006
BiDil® (hydralazine and isosorbide dinitrate) represents an interesting application of personalized medicine - the first… Expand
Is this relevant?
2005
2005
2005
903 Illuminating BiDil BiDil is a recently approved therapy indicated for congestive heart failure patients already taking… Expand
Is this relevant?